£795.00

The 2021-2026 World Outlook for Antihypertensive Drugs

Price data last checked 27 day(s) ago - will refresh soon

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

It has never been this cheap. We have no record of a lower price.

£795 today · cheaper than every other day in the last 3 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 64 days · 64 data points (no recent data)

Historical
Generating forecast…
£795.00 £755.25 £771.15 £787.05 £802.95 £818.85 £834.75 10 June 2026 25 June 2026 11 July 2026 27 July 2026 12 August 2026

Price Distribution

Price distribution over 64 days • 1 price levels

Days at Price
64 days 0 16 32 48 64 £795 Days at Price

Price Analysis

Most common price: £795 (64 days, 100.0%)

Price range: £795 - £795

Price levels: 1 different prices over 64 days

Description

This study covers the world outlook for antihypertensive drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis others. Using econometric models which project fundamental economic dynamics within each country and across countries, latent demand estimates are created. This report does not discuss the specific players in the market serving the latent demand, nor specific details at the product level. The study also does not consider short-term cyclicalities that might affect realized sales. The study, therefore, is strategic in nature, taking an aggregate and long-run view, irrespective of the players or products involved. This study does not report actual sales data (which are simply unavailable, in a comparable or consistent manner in virtually all of the countries of the world). This study gives, however, my estimates for the worldwide latent demand, or the P.I.E., for antihypertensive drugs. It also shows how the P.I.E. is divided across the world's regional and national markets. For each country, I also show my estimates of how the P.I.E. grows over time (positive or negative growth). In order to make these estimates, a multi-stage methodology was employed that is often taught in courses on international strategic planning at graduate schools of business.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
13 February 2020
Listed Since
25 March 2020

Similar Products You Might Like

The 2016-2021 World Outlook for Anti-Hypertensive Drugs
99% match

The 2016-2021 World Outlook for Anti-Hypertensive Drugs

£995.00 13 Aug 2026
The 2013-2018 Outlook for Anti-Hypertensive Drugs in India
98% match

The 2013-2018 Outlook for Anti-Hypertensive Drugs in India

£495.00 15 Aug 2026
The 2025-2030 World Outlook for Hypertension Management Devices
98% match

The 2025-2030 World Outlook for Hypertension Management Devices

£790.00 15 Aug 2026
The 2023-2028 Outlook for Anti-Hypertensive Diuretic Drugs in India
98% match

The 2023-2028 Outlook for Anti-Hypertensive Diuretic Drugs in India

£515.00 26 Aug 2026
The 2023-2028 Outlook for Anti-Hypertensive Diuretic Drugs in the United States
97% match

The 2023-2028 Outlook for Anti-Hypertensive Diuretic Drugs in the United States

£520.00 02 Sep 2026
The 2016-2021 Outlook for Electronic Handheld Blood Pressure Devices in the United States
97% match

The 2016-2021 Outlook for Electronic Handheld Blood Pressure Devices in the United States

£595.00 04 Sep 2026
The 2023-2028 Outlook for Renin-Angiotensin System-Blocking Cardiovascular Drugs in the United States
97% match

The 2023-2028 Outlook for Renin-Angiotensin System-Blocking Cardiovascular Drugs in the United States

£520.00 03 Sep 2026
The 2023-2028 World Outlook for Electronic Handheld Blood Pressure Devices
97% match

The 2023-2028 World Outlook for Electronic Handheld Blood Pressure Devices

£795.00 11 Jul 2026
The 2023-2028 Outlook for Renin-Angiotensin System-Blocking Cardiovascular Drugs in India
97% match

The 2023-2028 Outlook for Renin-Angiotensin System-Blocking Cardiovascular Drugs in India

£515.00 25 Aug 2026
The 2016-2021 Outlook for Electronic Handheld Blood Pressure Devices in Greater China
97% match

The 2016-2021 Outlook for Electronic Handheld Blood Pressure Devices in Greater China

£595.00 06 Sep 2026
The 2016-2021 Outlook for Electronic Handheld Blood Pressure Devices in Japan
97% match

The 2016-2021 Outlook for Electronic Handheld Blood Pressure Devices in Japan

£595.00 03 Sep 2026
The 2023-2028 Outlook for Blood Pressure Monitoring and Measurement Instruments in the United States
97% match

The 2023-2028 Outlook for Blood Pressure Monitoring and Measurement Instruments in the United States

£520.00 27 Aug 2026
Antihypertensive Drugs: Pharmacology, Medical Uses & Potential Side Effects
97% match

Antihypertensive Drugs: Pharmacology, Medical Uses & Potential Side Effects

Nova Science Publishers Inc

£133.36 10 Jul 2026
The 2023-2028 Outlook for Blood Pressure Monitoring and Measurement Instruments in India
97% match

The 2023-2028 Outlook for Blood Pressure Monitoring and Measurement Instruments in India

£515.00 25 Aug 2026
The 2025-2030 World Outlook for Self-Care Blood Pressure Monitors
97% match

The 2025-2030 World Outlook for Self-Care Blood Pressure Monitors

£790.00 03 Sep 2026
The 2023-2028 Outlook for Anti-Hypertensive Diuretic Drugs in Japan
97% match

The 2023-2028 Outlook for Anti-Hypertensive Diuretic Drugs in Japan

£495.00 22 Aug 2026
The 2023-2028 Outlook for Anti-Hypertensive Diuretic Drugs in China
97% match

The 2023-2028 Outlook for Anti-Hypertensive Diuretic Drugs in China

£495.00 20 Aug 2026
The 2023-2028 World Outlook for Home Blood Pressure Monitoring Devices
97% match

The 2023-2028 World Outlook for Home Blood Pressure Monitoring Devices

Price unavailable
The 2016 Report on Electronic Handheld Blood Pressure Devices: World Market Segmentation by City
97% match

The 2016 Report on Electronic Handheld Blood Pressure Devices: World Market Segmentation by City

£995.00 22 Aug 2026
The 2021-2026 World Outlook for Ace Inhibitor Vasodilator Pharmaceuticals
97% match

The 2021-2026 World Outlook for Ace Inhibitor Vasodilator Pharmaceuticals

£795.00 11 Jul 2026
The 2023-2028 Outlook for Renin-Angiotensin System-Blocking Cardiovascular Drugs in China
97% match

The 2023-2028 Outlook for Renin-Angiotensin System-Blocking Cardiovascular Drugs in China

£495.00 15 Jul 2026
The 2023-2028 Outlook for Renin-Angiotensin System-Blocking Cardiovascular Drugs in Japan
96% match

The 2023-2028 Outlook for Renin-Angiotensin System-Blocking Cardiovascular Drugs in Japan

£495.00 25 Aug 2026
The 2023-2028 Outlook for Anti-Hypertensive Diuretic Drugs for US Zip Codes
96% match

The 2023-2028 Outlook for Anti-Hypertensive Diuretic Drugs for US Zip Codes

£490.00 26 Aug 2026
The 2025-2030 World Outlook for Aldosterone-Antagonist Dilated Cardiomyopathy Therapeutics
96% match

The 2025-2030 World Outlook for Aldosterone-Antagonist Dilated Cardiomyopathy Therapeutics

£790.00 21 Aug 2026